MEDFORD, Mass., March 13, 2025--(BUSINESS WIRE)--Myrobalan Therapeutics, a biotechnology company developing potent, selective, and brain-penetrant oral small-molecule therapies to restore brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback